Human Gene TGFB1 (ENST00000221930.6_7) from GENCODE V47lift37
  Description: transforming growth factor beta 1 (from RefSeq NM_000660.7)
Gencode Transcript: ENST00000221930.6_7
Gencode Gene: ENSG00000105329.11_13
Transcript (Including UTRs)
   Position: hg19 chr19:41,836,228-41,859,827 Size: 23,600 Total Exon Count: 7 Strand: -
Coding Region
   Position: hg19 chr19:41,836,957-41,858,949 Size: 21,993 Coding Exon Count: 7 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviewsModel Information
Methods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr19:41,836,228-41,859,827)mRNA (may differ from genome)Protein (390 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: TGFB1_HUMAN
DESCRIPTION: RecName: Full=Transforming growth factor beta-1; Short=TGF-beta-1; Contains: RecName: Full=Latency-associated peptide; Short=LAP; Flags: Precursor;
FUNCTION: Multifunctional protein that controls proliferation, differentiation and other functions in many cell types. Many cells synthesize TGFB1 and have specific receptors for it. It positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts.
SUBUNIT: Homodimer; disulfide-linked, or heterodimer with TGFB2 (By similarity). Secreted and stored as a biologically inactive form in the extracellular matrix in a 290 kDa complex (large latent TGF-beta1 complex) containing the TGFB1 homodimer, the latency-associated peptide (LAP), and the latent TGFB1 binding protein-1 (LTBP1). The complex without LTBP1 is known as the'small latent TGF-beta1 complex'. Dissociation of the TGFB1 from LAP is required for growth factor activation and biological activity. Release of the large latent TGF-beta1 complex from the extracellular matrix is carried out by the matrix metalloproteinase MMP3 (By similarity). May interact with THSD4; this interaction may lead to sequestration by FBN1 microfibril assembly and attenuation of TGFB signaling. Interacts with the serine proteases, HTRA1 and HTRA3: the interaction with either inhibits TGFB1-mediated signaling. The HTRA protease activity is required for this inhibition (By similarity). Interacts with CD109, DPT and ASPN.
INTERACTION: P05067:APP; NbExp=2; IntAct=EBI-779636, EBI-77613; P17813:ENG; NbExp=2; IntAct=EBI-779636, EBI-2834630; P36897:TGFBR1; NbExp=2; IntAct=EBI-779636, EBI-1027557; P37173:TGFBR2; NbExp=4; IntAct=EBI-779636, EBI-296151; Q03167:TGFBR3; NbExp=2; IntAct=EBI-779636, EBI-2852679;
SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.
TISSUE SPECIFICITY: Highly expressed in bone. Abundantly expressed in articular cartilage and chondrocytes and is increased in osteoarthritis (OA). Co-localizes with ASPN in chondrocytes within OA lesions of articular cartilage.
INDUCTION: Activated in vitro at pH below 3.5 and over 12.5.
DOMAIN: The 'straitjacket' and 'arm' domains encircle the growth factor monomers and are fastened together by strong bonding between Lys-56 and Tyr-103/Tyr-104. Activation of TGF-beta1 requires the binding of integrin alpha-V to an RGD sequence in the prodomain and exertion of force on this domain, which is held in the extracellular matrix by latent TGF-beta binding proteins. The sheer physical force unfastens the straitjacket and releases the active growth factor dimer (By similarity).
PTM: Glycosylated.
PTM: The precursor is cleaved into mature TGF-beta-1 and LAP, which remains non-covalently linked to mature TGF-beta-1 rendering it inactive.
POLYMORPHISM: In post-menopausal Japanese women, the frequency of Leu-10 is higher in subjects with osteoporosis than in controls.
DISEASE: Defects in TGFB1 are the cause of Camurati-Engelmann disease (CE) [MIM:131300]; also known as progressive diaphyseal dysplasia 1 (DPD1). CE is an autosomal dominant disorder characterized by hyperostosis and sclerosis of the diaphyses of long bones. The disease typically presents in early childhood with pain, muscular weakness and waddling gait, and in some cases other features such as exophthalmos, facial paralysis, hearing difficulties and loss of vision.
SIMILARITY: Belongs to the TGF-beta family.
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/TGFB1";
WEB RESOURCE: Name=Wikipedia; Note=TGF beta-1 entry; URL="http://en.wikipedia.org/wiki/TGF_beta_1";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: TGFB1
Diseases sorted by gene-association score: camurati-engelmann disease* (1756), cystic fibrosis* (433), renal fibrosis (36), ureteral obstruction (29), hypertrophic scars (28), keloids (27), urinary tract obstruction (25), interstitial lung disease (25), gingival overgrowth (23), peyronie's disease (22), biliary atresia (20), communicating hydrocephalus (19), facial paralysis (18), dupuytren contracture (18), nephrogenic systemic fibrosis (18), epithelial basement membrane dystrophy (18), burn scar (18), diffuse scleroderma (17), ureteral disease (17), gingival fibromatosis (16), nephrosclerosis (16), eosinophilia-myalgia syndrome (15), submandibular gland disease (15), oral submucous fibrosis (14), diabetic foot ulcers (13), juvenile myasthenia gravis (13), acoustic neuroma (12), stiff skin syndrome (12), localized scleroderma (12), idiopathic interstitial pneumonia (12), osteoarthritis (12), pulmonary fibrosis (12), pneumoconiosis (12), otosclerosis (11), hydronephrosis (11), systemic scleroderma (11), congenital absence of the vas deferens (11), idiopathic neutropenia (10), hereditary hemorrhagic telangiectasia (10), bone fracture (10), cholecystolithiasis (10), heart valve disease (10), penile disease (9), pustulosis palmaris et plantaris (9), rheumatic heart disease (9), posterior urethral valves (9), shprintzen-goldberg syndrome (9), tuberculoid leprosy (9), geleophysic dysplasia (9), osteochondrosis (9), strongyloidiasis (9), neutropenia, cyclic (9), lattice corneal dystrophy (8), liver cirrhosis (8), spinal cord injury (8), chondromyxoid fibroma (8), familial vesicoureteral reflux (8), laryngitis (8), silicosis (8), ocular cicatricial pemphigoid (8), chronic active epstein-barr virus infection (7), chagas disease (7), vitreoretinopathy, neovascular inflammatory (7), beryllium disease (7), clonorchiasis (7), recessive dystrophic epidermolysis bullosa (7), eosinophilic variant of chromophobe renal cell carcinoma (7), moyamoya disease (7), exophthalmos (7), fibromuscular dysplasia (7), pancreatic cancer (7), hyperostosis (6), vesicoureteral reflux (6), rapidly progressive glomerulonephritis (6), giardiasis (6), pulmonary fibrosis, idiopathic (6), prostatitis (6), hepatocellular carcinoma (6), eisenmenger syndrome (6), neuroma (6), chronic fatigue syndrome (6), microvascular complications of diabetes 3 (6), sick sinus syndrome (6), crouzon syndrome (6), esophagitis (5), end stage renal failure (5), nonspecific interstitial pneumonia (5), iga glomerulonephritis (5), diffuse mesangial sclerosis (5), hepatitis a (5), portal hypertension (5), craniodiaphyseal dysplasia (5), paranasal sinus disease (5), giant hemangioma (5), hepatitis b (5), epidermodysplasia verruciformis (5), osteofibrous dysplasia (5), cataract 31, multiple types (5), myelofibrosis with myeloid metaplasia, somatic (5), glomerulonephritis (5), focal segmental glomerulosclerosis (4), lacrimal duct obstruction (4), lung disease (4), osteoporosis (4), ascending cholangitis (4), liver disease (4), gingival disease (4), norwegian scabies (4), leishmaniasis (4), aortic valve disease 1 (4), calcific tendinitis (3), colorectal cancer (3), sialolithiasis (3), breast cancer (3), stomach cancer (3), malaria (3), dilated cardiomyopathy (3), differentiated thyroid carcinoma (3), renal cell carcinoma (3), prostate cancer (3), rheumatoid arthritis (2), endometrial cancer (2), hydrocephalus (2), lung cancer (2), urinary system disease (2), diamond-blackfan anemia (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 146.30 RPKM in Whole Blood
Total median expression: 1293.68 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -395.40878-0.450 Picture PostScript Text
3' UTR -271.70729-0.373 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR001839 - TGF-b_C
IPR001111 - TGF-b_N
IPR016319 - TGF-beta
IPR015615 - TGF-beta-rel
IPR003939 - TGFb1
IPR017948 - TGFb_CS

Pfam Domains:
PF00019 - Transforming growth factor beta like domain
PF00688 - TGF-beta propeptide

SCOP Domains:
57501 - Cystine-knot cytokines

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1KLA - NMR MuPIT 1KLC - NMR MuPIT 1KLD - NMR 3KFD - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on P01137
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0003823 antigen binding
GO:0005114 type II transforming growth factor beta receptor binding
GO:0005125 cytokine activity
GO:0005160 transforming growth factor beta receptor binding
GO:0005515 protein binding
GO:0008083 growth factor activity
GO:0019899 enzyme binding
GO:0034713 type I transforming growth factor beta receptor binding
GO:0034714 type III transforming growth factor beta receptor binding
GO:0042802 identical protein binding
GO:0042803 protein homodimerization activity
GO:0043539 protein serine/threonine kinase activator activity
GO:0046982 protein heterodimerization activity
GO:0047485 protein N-terminus binding

Biological Process:
GO:0000060 protein import into nucleus, translocation
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0000165 MAPK cascade
GO:0001570 vasculogenesis
GO:0001657 ureteric bud development
GO:0001666 response to hypoxia
GO:0001763 morphogenesis of a branching structure
GO:0001775 cell activation
GO:0001837 epithelial to mesenchymal transition
GO:0001843 neural tube closure
GO:0001933 negative regulation of protein phosphorylation
GO:0001934 positive regulation of protein phosphorylation
GO:0002028 regulation of sodium ion transport
GO:0002062 chondrocyte differentiation
GO:0002244 hematopoietic progenitor cell differentiation
GO:0002248 connective tissue replacement involved in inflammatory response wound healing
GO:0002460 adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
GO:0002513 tolerance induction to self antigen
GO:0002576 platelet degranulation
GO:0003179 heart valve morphogenesis
GO:0006468 protein phosphorylation
GO:0006611 protein export from nucleus
GO:0006754 ATP biosynthetic process
GO:0006796 phosphate-containing compound metabolic process
GO:0006874 cellular calcium ion homeostasis
GO:0006954 inflammatory response
GO:0007050 cell cycle arrest
GO:0007093 mitotic cell cycle checkpoint
GO:0007173 epidermal growth factor receptor signaling pathway
GO:0007179 transforming growth factor beta receptor signaling pathway
GO:0007182 common-partner SMAD protein phosphorylation
GO:0007183 SMAD protein complex assembly
GO:0007219 Notch signaling pathway
GO:0007406 negative regulation of neuroblast proliferation
GO:0007435 salivary gland morphogenesis
GO:0007492 endoderm development
GO:0007507 heart development
GO:0007565 female pregnancy
GO:0007568 aging
GO:0008283 cell proliferation
GO:0008284 positive regulation of cell proliferation
GO:0008285 negative regulation of cell proliferation
GO:0008354 germ cell migration
GO:0009314 response to radiation
GO:0009611 response to wounding
GO:0009749 response to glucose
GO:0009817 defense response to fungus, incompatible interaction
GO:0010033 response to organic substance
GO:0010468 regulation of gene expression
GO:0010469 regulation of receptor activity
GO:0010575 positive regulation of vascular endothelial growth factor production
GO:0010628 positive regulation of gene expression
GO:0010629 negative regulation of gene expression
GO:0010716 negative regulation of extracellular matrix disassembly
GO:0010718 positive regulation of epithelial to mesenchymal transition
GO:0010742 macrophage derived foam cell differentiation
GO:0010763 positive regulation of fibroblast migration
GO:0010800 positive regulation of peptidyl-threonine phosphorylation
GO:0010862 positive regulation of pathway-restricted SMAD protein phosphorylation
GO:0010936 negative regulation of macrophage cytokine production
GO:0014003 oligodendrocyte development
GO:0014070 response to organic cyclic compound
GO:0016202 regulation of striated muscle tissue development
GO:0016477 cell migration
GO:0017015 regulation of transforming growth factor beta receptor signaling pathway
GO:0019049 evasion or tolerance of host defenses by virus
GO:0019221 cytokine-mediated signaling pathway
GO:0021915 neural tube development
GO:0022408 negative regulation of cell-cell adhesion
GO:0030214 hyaluronan catabolic process
GO:0030217 T cell differentiation
GO:0030279 negative regulation of ossification
GO:0030308 negative regulation of cell growth
GO:0030316 osteoclast differentiation
GO:0030334 regulation of cell migration
GO:0030335 positive regulation of cell migration
GO:0030501 positive regulation of bone mineralization
GO:0030509 BMP signaling pathway
GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway
GO:0030879 mammary gland development
GO:0031065 positive regulation of histone deacetylation
GO:0031100 animal organ regeneration
GO:0031293 membrane protein intracellular domain proteolysis
GO:0031334 positive regulation of protein complex assembly
GO:0031536 positive regulation of exit from mitosis
GO:0031663 lipopolysaccharide-mediated signaling pathway
GO:0032270 positive regulation of cellular protein metabolic process
GO:0032355 response to estradiol
GO:0032570 response to progesterone
GO:0032667 regulation of interleukin-23 production
GO:0032700 negative regulation of interleukin-17 production
GO:0032740 positive regulation of interleukin-17 production
GO:0032801 receptor catabolic process
GO:0032930 positive regulation of superoxide anion generation
GO:0032943 mononuclear cell proliferation
GO:0032967 positive regulation of collagen biosynthetic process
GO:0033138 positive regulation of peptidyl-serine phosphorylation
GO:0033280 response to vitamin D
GO:0034616 response to laminar fluid shear stress
GO:0035066 positive regulation of histone acetylation
GO:0035307 positive regulation of protein dephosphorylation
GO:0035902 response to immobilization stress
GO:0042060 wound healing
GO:0042110 T cell activation
GO:0042127 regulation of cell proliferation
GO:0042130 negative regulation of T cell proliferation
GO:0042306 regulation of protein import into nucleus
GO:0042307 positive regulation of protein import into nucleus
GO:0042482 positive regulation of odontogenesis
GO:0042493 response to drug
GO:0042552 myelination
GO:0042981 regulation of apoptotic process
GO:0043011 myeloid dendritic cell differentiation
GO:0043029 T cell homeostasis
GO:0043065 positive regulation of apoptotic process
GO:0043117 positive regulation of vascular permeability
GO:0043406 positive regulation of MAP kinase activity
GO:0043491 protein kinase B signaling
GO:0043536 positive regulation of blood vessel endothelial cell migration
GO:0043537 negative regulation of blood vessel endothelial cell migration
GO:0043552 positive regulation of phosphatidylinositol 3-kinase activity
GO:0043932 ossification involved in bone remodeling
GO:0045066 regulatory T cell differentiation
GO:0045216 cell-cell junction organization
GO:0045589 regulation of regulatory T cell differentiation
GO:0045591 positive regulation of regulatory T cell differentiation
GO:0045596 negative regulation of cell differentiation
GO:0045599 negative regulation of fat cell differentiation
GO:0045662 negative regulation of myoblast differentiation
GO:0045786 negative regulation of cell cycle
GO:0045892 negative regulation of transcription, DNA-templated
GO:0045893 positive regulation of transcription, DNA-templated
GO:0045930 negative regulation of mitotic cell cycle
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0048146 positive regulation of fibroblast proliferation
GO:0048298 positive regulation of isotype switching to IgA isotypes
GO:0048468 cell development
GO:0048535 lymph node development
GO:0048565 digestive tract development
GO:0048642 negative regulation of skeletal muscle tissue development
GO:0048839 inner ear development
GO:0050679 positive regulation of epithelial cell proliferation
GO:0050680 negative regulation of epithelial cell proliferation
GO:0050714 positive regulation of protein secretion
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
GO:0050765 negative regulation of phagocytosis
GO:0050777 negative regulation of immune response
GO:0050868 negative regulation of T cell activation
GO:0050900 leukocyte migration
GO:0050921 positive regulation of chemotaxis
GO:0051092 positive regulation of NF-kappaB transcription factor activity
GO:0051098 regulation of binding
GO:0051101 regulation of DNA binding
GO:0051152 positive regulation of smooth muscle cell differentiation
GO:0051280 negative regulation of release of sequestered calcium ion into cytosol
GO:0051781 positive regulation of cell division
GO:0051897 positive regulation of protein kinase B signaling
GO:0055010 ventricular cardiac muscle tissue morphogenesis
GO:0060312 regulation of blood vessel remodeling
GO:0060325 face morphogenesis
GO:0060364 frontal suture morphogenesis
GO:0060389 pathway-restricted SMAD protein phosphorylation
GO:0060390 regulation of SMAD protein import into nucleus
GO:0060391 positive regulation of SMAD protein import into nucleus
GO:0060395 SMAD protein signal transduction
GO:0060744 mammary gland branching involved in thelarche
GO:0060751 branch elongation involved in mammary gland duct branching
GO:0060762 regulation of branching involved in mammary gland duct morphogenesis
GO:0060965 negative regulation of gene silencing by miRNA
GO:0061035 regulation of cartilage development
GO:0070306 lens fiber cell differentiation
GO:0070374 positive regulation of ERK1 and ERK2 cascade
GO:0070723 response to cholesterol
GO:0071158 positive regulation of cell cycle arrest
GO:0071260 cellular response to mechanical stimulus
GO:0071363 cellular response to growth factor stimulus
GO:0071407 cellular response to organic cyclic compound
GO:0071479 cellular response to ionizing radiation
GO:0071549 cellular response to dexamethasone stimulus
GO:0071560 cellular response to transforming growth factor beta stimulus
GO:0071677 positive regulation of mononuclear cell migration
GO:0085029 extracellular matrix assembly
GO:0090190 positive regulation of branching involved in ureteric bud morphogenesis
GO:0097191 extrinsic apoptotic signaling pathway
GO:0097421 liver regeneration
GO:1900126 negative regulation of hyaluronan biosynthetic process
GO:1900182 positive regulation of protein localization to nucleus
GO:1901203 positive regulation of extracellular matrix assembly
GO:1901666 positive regulation of NAD+ ADP-ribosyltransferase activity
GO:1902074 response to salt
GO:1902895 positive regulation of pri-miRNA transcription from RNA polymerase II promoter
GO:1903077 negative regulation of protein localization to plasma membrane
GO:1903799 negative regulation of production of miRNAs involved in gene silencing by miRNA
GO:1903800 positive regulation of production of miRNAs involved in gene silencing by miRNA
GO:1903911 positive regulation of receptor clustering
GO:1905313 transforming growth factor beta receptor signaling pathway involved in heart development
GO:1990314 cellular response to insulin-like growth factor stimulus
GO:1990402 embryonic liver development
GO:2000249 regulation of actin cytoskeleton reorganization
GO:2000679 positive regulation of transcription regulatory region DNA binding
GO:2000727 positive regulation of cardiac muscle cell differentiation
GO:0006915 apoptotic process
GO:1902893 regulation of pri-miRNA transcription from RNA polymerase II promoter
GO:1905005 regulation of epithelial to mesenchymal transition involved in endocardial cushion formation

Cellular Component:
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005796 Golgi lumen
GO:0005886 plasma membrane
GO:0009986 cell surface
GO:0030141 secretory granule
GO:0030424 axon
GO:0031012 extracellular matrix
GO:0031093 platelet alpha granule lumen
GO:0043025 neuronal cell body
GO:0072562 blood microparticle
GO:0005902 microvillus


-  Descriptions from all associated GenBank mRNAs
  JD431333 - Sequence 412357 from Patent EP1572962.
X02812 - Human mRNA for transforming growth factor-beta (TGF-beta).
JD237455 - Sequence 218479 from Patent EP1572962.
JD152573 - Sequence 133597 from Patent EP1572962.
JD325764 - Sequence 306788 from Patent EP1572962.
JD145202 - Sequence 126226 from Patent EP1572962.
JD487492 - Sequence 468516 from Patent EP1572962.
JD545828 - Sequence 526852 from Patent EP1572962.
JD075264 - Sequence 56288 from Patent EP1572962.
JD118807 - Sequence 99831 from Patent EP1572962.
JD085625 - Sequence 66649 from Patent EP1572962.
JD047434 - Sequence 28458 from Patent EP1572962.
JD171529 - Sequence 152553 from Patent EP1572962.
JD557779 - Sequence 538803 from Patent EP1572962.
JD433407 - Sequence 414431 from Patent EP1572962.
JD327863 - Sequence 308887 from Patent EP1572962.
JD185903 - Sequence 166927 from Patent EP1572962.
JD067985 - Sequence 49009 from Patent EP1572962.
JD086348 - Sequence 67372 from Patent EP1572962.
JD247015 - Sequence 228039 from Patent EP1572962.
JD413444 - Sequence 394468 from Patent EP1572962.
E00973 - cDNA encoding human TGF-beta.
JD121542 - Sequence 102566 from Patent EP1572962.
JD255101 - Sequence 236125 from Patent EP1572962.
JD255100 - Sequence 236124 from Patent EP1572962.
JD488828 - Sequence 469852 from Patent EP1572962.
JD375058 - Sequence 356082 from Patent EP1572962.
JD452182 - Sequence 433206 from Patent EP1572962.
M38449 - Homo sapiens transforming growth factor-beta (TGF-beta) mRNA, partial cds.
HV703915 - WO 2012050181-A/1: PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS.
LV503004 - JP 2017000155-A/1: PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS.
MA378590 - JP 2018088923-A/1: PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS.
JD318412 - Sequence 299436 from Patent EP1572962.
JD398884 - Sequence 379908 from Patent EP1572962.
JD150471 - Sequence 131495 from Patent EP1572962.
JD261031 - Sequence 242055 from Patent EP1572962.
CQ873703 - Sequence 122 from Patent WO2004076622.
DD413540 - Regulation of Mammalian Cells.
JD416668 - Sequence 397692 from Patent EP1572962.
JD416667 - Sequence 397691 from Patent EP1572962.
JD366857 - Sequence 347881 from Patent EP1572962.
JD386595 - Sequence 367619 from Patent EP1572962.
HW061212 - JP 2012529430-A/87: METHODS FOR TREATING CHRONIC KIDNEY DISEASE.
JB252020 - Sequence 87 from Patent EP2440214.
LF384230 - JP 2014500723-A/191733: Polycomb-Associated Non-Coding RNAs.
LP764919 - Sequence 87 from Patent EP3276004.
BC000125 - Homo sapiens transforming growth factor, beta 1, mRNA (cDNA clone MGC:3119 IMAGE:3351664), complete cds.
BC001180 - Homo sapiens transforming growth factor, beta 1, mRNA (cDNA clone MGC:2323 IMAGE:3356605), complete cds.
BC022242 - Homo sapiens transforming growth factor, beta 1, mRNA (cDNA clone MGC:22008 IMAGE:4399762), complete cds.
AK291907 - Homo sapiens cDNA FLJ75750 complete cds, highly similar to Homo sapiens transforming growth factor, beta 1 (Camurati-Engelmanndisease) (TGFB1), mRNA.
E03028 - DNA encoding human prepro TGF-beta1.
JD116363 - Sequence 97387 from Patent EP1572962.
JD121945 - Sequence 102969 from Patent EP1572962.
JD389828 - Sequence 370852 from Patent EP1572962.
JD190584 - Sequence 171608 from Patent EP1572962.
JD191218 - Sequence 172242 from Patent EP1572962.
A23751 - TGF-beta1 coding region.
EU832132 - Synthetic construct Homo sapiens clone HAIB:100067161; DKFZo008D1025 transforming growth factor, beta 1 protein (TGFB1) gene, encodes complete protein.
KJ897662 - Synthetic construct Homo sapiens clone ccsbBroadEn_07056 TGFB1 gene, encodes complete protein.
EU832225 - Synthetic construct Homo sapiens clone HAIB:100067254; DKFZo004D1026 transforming growth factor, beta 1 protein (TGFB1) gene, encodes complete protein.
BT007245 - Homo sapiens transforming growth factor, beta 1 (Camurati-Engelmann disease) mRNA, complete cds.
A23758 - TGF-beta3(44/45)beta1 hybrid coding region.
CU692504 - Synthetic construct Homo sapiens gateway clone IMAGE:100019204 5' read TGFB1 mRNA.
A23755 - TGF-beta1(44/45)beta3 hybrid coding region.
A23754 - TGF-beta1(44/45)beta2 hybrid coding region.
AK307742 - Homo sapiens cDNA, FLJ97690.
LF367150 - JP 2014500723-A/174653: Polycomb-Associated Non-Coding RNAs.
AY820829 - Homo sapiens transforming growth factor beta 1 mRNA, partial cds.
LF367148 - JP 2014500723-A/174651: Polycomb-Associated Non-Coding RNAs.
LF212094 - JP 2014500723-A/19597: Polycomb-Associated Non-Coding RNAs.
JD476913 - Sequence 457937 from Patent EP1572962.
LF213070 - JP 2014500723-A/20573: Polycomb-Associated Non-Coding RNAs.
JD408098 - Sequence 389122 from Patent EP1572962.
JD394113 - Sequence 375137 from Patent EP1572962.
JD126900 - Sequence 107924 from Patent EP1572962.
JD054667 - Sequence 35691 from Patent EP1572962.
JD380735 - Sequence 361759 from Patent EP1572962.
JD329740 - Sequence 310764 from Patent EP1572962.
LF367147 - JP 2014500723-A/174650: Polycomb-Associated Non-Coding RNAs.
JD142470 - Sequence 123494 from Patent EP1572962.
JD520508 - Sequence 501532 from Patent EP1572962.
JD147618 - Sequence 128642 from Patent EP1572962.
JD234287 - Sequence 215311 from Patent EP1572962.
JD340379 - Sequence 321403 from Patent EP1572962.
JD471505 - Sequence 452529 from Patent EP1572962.
JD484078 - Sequence 465102 from Patent EP1572962.
JD458484 - Sequence 439508 from Patent EP1572962.
LF367146 - JP 2014500723-A/174649: Polycomb-Associated Non-Coding RNAs.
JD205505 - Sequence 186529 from Patent EP1572962.
JD141664 - Sequence 122688 from Patent EP1572962.
JD210619 - Sequence 191643 from Patent EP1572962.
MA619807 - JP 2018138019-A/191733: Polycomb-Associated Non-Coding RNAs.
MA602727 - JP 2018138019-A/174653: Polycomb-Associated Non-Coding RNAs.
MA602725 - JP 2018138019-A/174651: Polycomb-Associated Non-Coding RNAs.
MA602724 - JP 2018138019-A/174650: Polycomb-Associated Non-Coding RNAs.
MA602723 - JP 2018138019-A/174649: Polycomb-Associated Non-Coding RNAs.
MA447671 - JP 2018138019-A/19597: Polycomb-Associated Non-Coding RNAs.
MA448647 - JP 2018138019-A/20573: Polycomb-Associated Non-Coding RNAs.
MB023309 - WO 2019074110-A/5: A single-stranded nucleic acid molecule and a production method thereof.
MP202690 - Sequence 1 from Patent WO2019090263.
MP245291 - Sequence 1 from Patent EP3517614.

-  Biochemical and Signaling Pathways
  BioCarta from NCI Cancer Genome Anatomy Project
h_p38mapkPathway - p38 MAPK Signaling Pathway
h_erythPathway - Erythrocyte Differentiation Pathway
h_inflamPathway - Cytokines and Inflammatory Response
h_mapkPathway - MAPKinase Signaling Pathway
h_tgfbPathway - TGF beta signaling pathway
h_tob1Pathway - Role of Tob in T-cell activation
h_alkPathway - ALK in cardiac myocytes
h_ctcfPathway - CTCF: First Multivalent Nuclear Factor
h_nktPathway - Selective expression of chemokine receptors during T-cell polarization
h_slrp2Pathway - Function of SLRP in Bone: An Integrated View
h_g1Pathway - Cell Cycle: G1/S Check Point
h_il1rPathway - Signal transduction through IL1R

Reactome (by CSHL, EBI, and GO)

Protein P01137 (Reactome details) participates in the following event(s):

R-HSA-2731078 Syndecans 2, (4) bind TGFB1
R-HSA-170844 Latent TGF-beta-1 is cleaved by furin
R-HSA-170861 Dimeric TGF-beta-1 binds to the receptor
R-HSA-3645778 TGFB1 binds TGFBR2 KD Mutant Dimers
R-HSA-168865 NA activation of TGF-beta
R-HSA-177107 Secretion and activation of the latent large complex of TGF-beta-1
R-HSA-2395320 Latent TGF-beta-1 binds integrins
R-HSA-2395364 LTBP4 binds TGF-Beta-1
R-HSA-2327886 SLRPs bind TGF Beta
R-HSA-8870732 PSGs bind proteoglycans and TGF-beta1
R-HSA-481007 Exocytosis of platelet alpha granule contents
R-HSA-170843 TGFBR2 phosphorylates TGFBR1
R-HSA-170846 TGFBR2 recruits TGFBR1
R-HSA-170835 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3
R-HSA-173483 BAMBI interferes with the interaction of type I receptor with type II receptor
R-HSA-173512 I-SMAD competes with SMAD2/3 for type I receptor (TGFBR1)
R-HSA-178218 SMAD7:SMURF complex binds to phosphorylated TGFBR1
R-HSA-2127562 STRAP binds phosphorylated TGF-beta receptor complex
R-NUL-2128982 Strap binds phosphorylated TGF-beta receptor complex
R-NUL-2169036 Smad7:SMURF1 binds phosphorylated TGFBR1
R-NUL-2169043 Smad7:SMURF2 binds phosphorylated TGFBR1
R-NUL-2176431 Smad7 recruits NEDD4L to activated TGF-beta receptor complex
R-HSA-3702153 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 MH2 domain mutants
R-HSA-3713560 An anchoring protein, ZFYVE9 (SARA), recruits SMAD2/3 phosphorylation motif mutants
R-HSA-2134519 TGFBR2 is recruited to tight junctions after TGF-beta stimulation
R-NUL-2161160 TGFBR2 is recruited to tight junctions-associated, Pard6a-bound, TGFBR1 after TGF-beta stimulation
R-HSA-3656484 TGFBR2 recruits TGFBR1 KD Mutants
R-HSA-170850 Phosphorylated SMAD2/3 dissociates from TGFBR
R-HSA-3702186 Phosphorylated SMAD2/3 MH2 domain mutants dissociate from TGFBR
R-HSA-170868 Activated type I receptor phosphorylates SMAD2/3 directly
R-HSA-178178 PP1 dephosphorylates TGFBR1
R-NUL-2167872 PP1CC dephosphorylates TGFBR1
R-NUL-2167890 Smad7 recruits GADD34:PP1CC to phosphorylated TGF-beta receptor complex
R-HSA-3645786 TGFBR2 mutant dimers recruit TGFBR1
R-HSA-3656517 TGFBR2 phosphorylates TGFBR1 KD Mutants
R-HSA-3702184 Activated type I receptor phosphorylates SMAD2/3 MH2 domain mutants directly
R-HSA-2395328 LTBP1, LTBP3 bind TGF-Beta
R-HSA-2134532 TGFBR2 phosphorylates TGFBR1 and PARD6A
R-NUL-2161165 TGFBR2 phosphorylates Pard6a
R-HSA-178189 SMAD7 recruits GADD34:PP1 to phosphorylated TGFBR
R-HSA-2128994 STRAP stabilizes interaction of activated TGF-beta receptor complex with SMAD7
R-HSA-2160932 SMURF1 binds phosphorylated PARD6A
R-HSA-2169050 SMURFs/NEDD4L ubiquitinate phosphorylated TGFBR1 and SMAD7
R-NUL-2176396 SMURF1 ubiquitinates Smad7 and phosphorylated TGFBR1
R-NUL-2176393 SMURF2 ubiquitinates Smad7 and phosphorylated TGFBR1
R-NUL-2176427 NEDD4L ubiquitinates Smad7 and TGFBR1
R-NUL-2179307 Uchl5 is recruited to TGF-beta receptor complex through Smad7
R-NUL-2179313 Uchl5 deubiquitinates TGFBR1
R-HSA-2179293 UCHL5 binds SMAD7 in complex with ubiquitinated TGFBR1
R-HSA-2179291 UCHL5, USP15 deubiquitinate TGFBR1
R-HSA-2160935 SMURF1 ubiquitinates RHOA
R-HSA-3000170 Syndecan interactions
R-HSA-2173789 TGF-beta receptor signaling activates SMADs
R-HSA-3642279 TGFBR2 MSI Frameshift Mutants in Cancer
R-HSA-3645790 TGFBR2 Kinase Domain Mutants in Cancer
R-HSA-168277 Influenza Virus Induced Apoptosis
R-HSA-2129379 Molecules associated with elastic fibres
R-HSA-3000178 ECM proteoglycans
R-HSA-3000171 Non-integrin membrane-ECM interactions
R-HSA-6785807 Interleukin-4 and 13 signaling
R-HSA-202733 Cell surface interactions at the vascular wall
R-HSA-114608 Platelet degranulation
R-HSA-170834 Signaling by TGF-beta Receptor Complex
R-HSA-2173788 Downregulation of TGF-beta receptor signaling
R-HSA-3315487 SMAD2/3 MH2 Domain Mutants in Cancer
R-HSA-3304356 SMAD2/3 Phosphorylation Motif Mutants in Cancer
R-HSA-2173791 TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
R-HSA-3656535 TGFBR1 LBD Mutants in Cancer
R-HSA-3656532 TGFBR1 KD Mutants in Cancer
R-HSA-3642278 Loss of Function of TGFBR2 in Cancer
R-HSA-168253 Host Interactions with Influenza Factors
R-HSA-1566948 Elastic fibre formation
R-HSA-1474244 Extracellular matrix organization
R-HSA-449147 Signaling by Interleukins
R-HSA-109582 Hemostasis
R-HSA-76005 Response to elevated platelet cytosolic Ca2+
R-HSA-9006936 Signaling by TGF-beta family members
R-HSA-3304349 Loss of Function of SMAD2/3 in Cancer
R-HSA-3656534 Loss of Function of TGFBR1 in Cancer
R-HSA-3304351 Signaling by TGF-beta Receptor Complex in Cancer
R-HSA-168254 Influenza Infection
R-HSA-1280215 Cytokine Signaling in Immune system
R-HSA-76002 Platelet activation, signaling and aggregation
R-HSA-162582 Signal Transduction
R-HSA-5689603 UCH proteinases
R-HSA-5663202 Diseases of signal transduction
R-HSA-5663205 Infectious disease
R-HSA-168256 Immune System
R-HSA-5688426 Deubiquitination
R-HSA-1643685 Disease
R-HSA-597592 Post-translational protein modification
R-HSA-392499 Metabolism of proteins

-  Other Names for This Gene
  Alternate Gene Symbols: A8K792, ENST00000221930.1, ENST00000221930.2, ENST00000221930.3, ENST00000221930.4, ENST00000221930.5, NM_000660, P01137, Q9UCG4, TGFB, TGFB1 , TGFB1_HUMAN, uc317dcu.1, uc317dcu.2
UCSC ID: ENST00000221930.6_7
RefSeq Accession: NM_000660.7
Protein: P01137 (aka TGFB1_HUMAN or TGF1_HUMAN)

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene TGFB1:
ced (Camurati-Engelmann Disease)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.